AMPK acts as a key energy sensor that promotes mitochondrial biogenesis and oxidative metabolism under metabolic stress, while HIF-1α, often activated in the hypoxic tumor microenvironment, reprograms cellular metabolism toward glycolysis and contributes to resistance to chemotherapy. The gene discussed is HIF1A; the disease is neoplasm.